HighTower Advisors’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,100
Closed -$7K 3613
2023
Q4
$7K Buy
+1,100
New +$4.57K ﹤0.01% 3457
2021
Q3
Sell
-1,000
Closed -$85K 3171
2021
Q2
$85K Buy
+1,000
New +$91.2K ﹤0.01% 2830
2021
Q1
Sell
-1,790
Closed -$104K 3039
2020
Q4
$104K Buy
1,790
+640
+56% +$30.1K ﹤0.01% 2344
2020
Q3
$38K Sell
1,150
-300
-21% -$11.4K ﹤0.01% 2320
2020
Q2
$68K Sell
1,450
-1,800
-55% -$50.1K ﹤0.01% 2177
2020
Q1
$53K Buy
3,250
+300
+10% +$7.14K ﹤0.01% 2003
2019
Q4
$81K Sell
2,950
-1,750
-37% -$46.8K ﹤0.01% 2093
2019
Q3
$138K Buy
4,700
+500
+12% +$14.9K ﹤0.01% 2129
2019
Q2
$121K Buy
4,200
+1,900
+83% +$64K ﹤0.01% 2141
2019
Q1
$95K Buy
2,300
+300
+15% +$10.8K ﹤0.01% 2074
2018
Q4
$62K Buy
2,000
+400
+25% +$14.9K ﹤0.01% 2012
2018
Q3
$69K Buy
+1,600
New +$45.3K ﹤0.01% 2096

Other funds holding AFMD

HighTower Advisors's AFMD Position: Q1 2024 in Review

HighTower Advisors sold out of Affimed (AFMD) in Q1 2024, closing a stake of 1,100 shares — an estimated $7K sold.

HighTower Advisors first reported a position in AFMD in Q3 2018 and held it in 12 quarters. The position peaked at $138K in Q3 2019. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

  • HighTower Advisors reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
  • HighTower Advisors sold 1,100 Affimed shares in Q1 2024, an estimated $7K.
  • HighTower Advisors first reported a position in Affimed in Q3 2018 and held it in 12 quarters.
  • HighTower Advisors's Affimed position peaked at $138K in Q3 2019.
  • 46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.